当前位置： SCI文献检索 > CONTRACEPTION期刊下所有文献 > Minimal androgenic activity of a new oral contraceptive containing norethindrone acetate and graduated doses of ethinyl estradiol.

Minimal androgenic activity of a new oral contraceptive containing norethindrone acetate and graduated doses of ethinyl estradiol.

Abstract：

:The pharmacokinetics and androgenic activity of Estrostep, a new oral contraceptive providing low-dose estrogen in a graduated sequence with a constant dose of progestin, were characterized in an open-label, nonrandomized study in 17 normally cycling women treated for three cycles with Estrostep. Women received 1 mg of norethindrone acetate daily combined with 20 microg of ethinyl estradiol daily for the first 5 days (1/20), 30 microg of ethinyl estradiol daily for the next 7 days (1/30), and 35 microg of ethinyl estradiol daily for 9 days (1/35). No medication was given for 7 days in each cycle to allow for withdrawal bleeding. Serial blood samples for the measurement of ethinyl estradiol and norethindrone concentrations were collected on days 5, 12, and 21 of the third treatment cycle for the 1/20, 1/30, and 1/35 dose, respectively. Sex hormone-binding globulin (SHBG) and free testosterone were measured at baseline, on day 1 of cycles 2 and 3 (SHBG only), and on days 5, 12, and 21 of cycle 3. Mean steady-state plasma ethinyl estradiol and norethindrone concentrations increased over cycle 3. The increases in ethinyl estradiol concentrations were proportional to dose. The increases in norethindrone concentrations were related to ethinyl estradiol-dependent increases in SHBG concentrations, which were 218%, 253%, and 296% of baseline values on days 5, 12, and 21, respectively. Mean plasma free testosterone concentrations decreased 47%, 60%, and 64% below baseline on days 5, 12, and 21 of cycle 3, respectively. Graduated ethinyl estradiol doses combined with a constant norethindrone acetate dose progressively increase SHBG and decrease free testosterone, which overrides any theoretic concerns of androgenic activity of norethindrone acetate. Although true androgenic activity can be determined only by assessing endpoints such as acne, hirsutism, and lipids in large controlled trials, the observed changes in circulating SHBG and free testosterone concentrations indicate that Estrostep has little, if any, intrinsic androgenic activity.

journal_name

Contraception

journal_title

Contraception

authors

Boyd RA,Zegarac EA,Posvar EL,Flack MR

doi

10.1016/s0010-7824(01)00179-2

subject

Has Abstract

pub_date

2001-02-01 00:00:00

pages

71-6

issue

2

eissn

0010-7824

issn

1879-0518

pii

S0010-7824(01)00179-2

journal_volume

63

pub_type

临床试验,杂志文章

相关文献

CONTRACEPTION文献大全
  • Increasing access to safe abortion services in rural India: experiences with medical abortion in a primary health center.

    abstract：INTRODUCTION:To increase access to safe abortion in rural India, the feasibility and acceptability of mifepristone-misoprostol abortion was assessed in a typical government run primary health center (PHC) in Nagpur district, Maharashtra State, that does not offer surgical abortion services and must refer off-site for e...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/j.contraception.2007.03.010

    authors： Mundle S,Elul B,Anand A,Kalyanwala S,Ughade S

    更新日期：2007-07-01 00:00:00

  • Can mifepristone medical abortion be simplified? A review of the evidence and questions for future research.

    abstract：:Mifepristone medical abortion has been a valuable addition to the reproductive health options of women. Aspects of its provision have however sometimes limited its accessibility and use. This article summarizes existing evidence for simplifying the provision of medical abortion and thus increasing its availability. We...

    journal_title：Contraception

    pub_type： 杂志文章,评审

    doi：10.1016/j.contraception.2006.11.011

    authors： Clark WH,Gold M,Grossman D,Winikoff B

    更新日期：2007-04-01 00:00:00

  • Interleukin-6 and tumor necrosis factor-alpha concentrations in the intrauterine cavity of postmenopausal women using an intrauterine delivery system releasing progesterone. A possible mechanism of action of the intrauterine device.

    abstract：:Intrauterine devices (IUD) provide effective contraception. The current study evaluates the concentration of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) in the intrauterine fluid of postmenopausal women using an intrauterine delivery system releasing progesterone (IDS-P). Intrauterine fluid was ob...

    journal_title：Contraception

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1016/s0010-7824(99)00014-1

    authors： Archer DF,DeSoto KR,Baker JM

    更新日期：1999-03-01 00:00:00

  • Mobile contraceptive application use in a clinical setting in addition to standard contraceptive counseling: A randomized controlled trial.

    abstract：OBJECTIVE:To evaluate the effect of miPlan, a waiting-room contraceptive counseling mobile application (app), on interest in discussing long-acting reversible contraception (LARC) during the clinical encounter and LARC uptake. STUDY DESIGN:This randomized controlled trial evaluated the miPlan contraceptive counseling ...

    journal_title：Contraception

    pub_type： 杂志文章,随机对照试验

    doi：10.1016/j.contraception.2018.07.001

    authors： Hebert LE,Hill BJ,Quinn M,Holl JL,Whitaker AK,Gilliam ML

    更新日期：2018-10-01 00:00:00

  • Expression of Hsp70-2 in rhesus monkey testis during germ cell apoptosis induced by testosterone undecanoate.

    abstract：:Hsp70-2 functions as a molecular chaperone that assists other proteins in their folding, transport and assembly into complexes, and is postulated to be linked to the mechanisms that inhibit apoptosis. Here we have determined the association between Hsp70-2 gene and germ cell apoptosis induced by a high dose of testost...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/s0010-7824(02)00357-8

    authors： Zhou XC,Zhang ZH,Hu ZY,Zou RJ,Liu YX

    更新日期：2002-11-01 00:00:00

  • Gender, relationship type and contraceptive use at first intercourse.

    abstract：BACKGROUND:Most of the sexually transmitted infection prevention programs fail to attend to the relationship type of individuals at first sexual intercourse and how it influences contraceptive behavior. STUDY DESIGN:A national sample of adolescents (3084 females and 2745 for males) was analyzed to determine the associ...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/j.contraception.2012.09.030

    authors： Gibbs L

    更新日期：2013-06-01 00:00:00

  • Inhibition by gossypol of cyclic AMP production in mouse Leydig cells.

    abstract：:Gossypol has been shown to inhibit steroidogenesis in leydig cells. This study examined the mechanism of this action by investigating the effect of gossypol on leydig cell hCG receptor binding, adenylate cyclase activity and cyclic AMP production in leydig cells. Gossypol had no effect on hCG binding to cell membranes...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/s0010-7824(86)80019-1

    authors： Pearce S,Sufi SB,O'Shaughnessy PJ,Donaldson A,Jeffcoate SL

    更新日期：1986-12-01 00:00:00

  • Use of intra- and extra-amniotic prostaglandins for the termination of pregnancies--report of multicentric trial in India.

    abstract：:The Indian Council of Medical Research initiated a multicentric trial with prostaglandins in 1976 to assess the safety and efficacy of their use in midtrimester abortions. PGF2 alpha and 15-Me-PGF2 alpha were compared using the intra-amniotic (I.A.) route. 15-Me-PGF2 alpha was also evaluated by extra-amniotic (E.A.) r...

    journal_title：Contraception

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1016/0010-7824(78)90048-3

    authors： Tejuja S,Choudhury SD,Manchanda PK

    更新日期：1978-12-01 00:00:00

  • Effect of a combination of ethinylestradiol 30 microg and drospirenone 3 mg on tolerance, cycle control, general well-being and fluid-related symptoms in women with premenstrual disorders requesting contraception.

    abstract：PURPOSE:Positive effects on premenstrual symptoms have been observed with low-dose oral contraceptives. Drospirenone is a synthetic progestogen with antiandrogenic and antimineralocorticoid effects. This open-label, multicenter study evaluated the effects of a combination of ethinylestradiol 30 microg and drospirenone ...

    journal_title：Contraception

    pub_type： 临床试验,杂志文章,多中心研究

    doi：10.1016/j.contraception.2005.10.016

    authors： Borges LE,Andrade RP,Aldrighi JM,Guazelli C,Yazlle ME,Isaia CF,Petracco A,Peixoto FC,Camargos AF

    更新日期：2006-12-01 00:00:00

  • Novel restricted access to vasectomy in Iran: addressing changing trends in vasectomy clients' characteristics over 16 years in northwestern Iran.

    abstract：OBJECTIVES:This study is designed to evaluate the popularity of vasectomy in Iran. The study was conducted to calculate the frequency of vasectomy over time, to compare vasectomy users' characteristics with the general population and whether these characteristics have changed over time. STUDY DESIGN:A cross-sectional ...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/j.contraception.2015.07.010

    authors： Farrokh-Eslamlou H,Oshnouei S,Alinejad V

    更新日期：2015-11-01 00:00:00

  • A multicenter efficacy and safety study of an oral contraceptive containing 150 micrograms desogestrel and 30 micrograms ethinyl estradiol.

    abstract：:The study reported herein is the primary efficacy and safety study conducted to support U.S. registration of an oral contraceptive containing 150 micrograms desogestrel and 30 micrograms ethinyl estradiol. A large multicenter study enrolled 1,221 women at 50 centers in the United Kingdom. A total of 11,656 cycles of e...

    journal_title：Contraception

    pub_type： 临床试验,杂志文章,多中心研究

    doi：10.1016/0010-7824(92)90094-a

    authors： Walling M

    更新日期：1992-10-01 00:00:00

  • HIV infection in women: impact on contraception.

    abstract：:A study was performed to evaluate the impact of knowledge of HIV infection (diagnosis) on contraception information and choices for HIV infected women. A questionnaire was given to 140 HIV infected women. Most of the studied population included young women with a low educational level. A significant increase in the kn...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/s0010-7824(02)00332-3

    authors： Magalhães J,Amaral E,Giraldo PC,Simoes JA

    更新日期：2002-08-01 00:00:00

  • Improving hysterosalpingogram confirmatory test follow-up after Essure hysteroscopic sterilization.

    abstract：BACKGROUND:Given the need for a 90-day post-Essure hysterosalpingogram (HSG) to confirm proper tubal placement and occlusion, we examined the impact of dedicating a staff nurse to schedule HSG appointments, call with appointment reminders and track HSG compliance for patients who had Essure. STUDY DESIGN:We performed ...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/j.contraception.2010.01.019

    authors： Guiahi M,Goldman KN,McElhinney MM,Olson CG

    更新日期：2010-06-01 00:00:00

  • Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.

    abstract：CONTEXT:There is concern that a new transdermal contraceptive patch containing ethinyl estradiol (EE) and the progestin norelgestromin increases the risk for venous thromboembolism (VTE) compared to previously marketed oral contraceptives (OCs). OBJECTIVE:Quantitative information was obtained on the risk of nonfatal V...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/j.contraception.2006.01.001

    authors： Jick SS,Kaye JA,Russmann S,Jick H

    更新日期：2006-03-01 00:00:00

  • The management of unacceptable bleeding patterns in etonogestrel-releasing contraceptive implant users.

    abstract：:The aim of this guidance is to review the management of unacceptable vaginal bleeding patterns in etonogestrel (ENG)-releasing contraceptive implant users concentrating, where possible, on the evidence for pharmacological treatments and identifying a pragmatic approach where this is not possible. This article was deve...

    journal_title：Contraception

    pub_type： 杂志文章,评审

    doi：10.1016/j.contraception.2010.08.001

    authors： Mansour D,Bahamondes L,Critchley H,Darney P,Fraser IS

    更新日期：2011-03-01 00:00:00

  • Reaching women where they are: eliminating the initial in-person medical abortion visit.

    abstract：:The requirement that every woman desiring medical abortion must come in person to a clinical facility to obtain the drugs is a substantial barrier for many women. To eliminate this requirement in the United States, two key components of the standard initial visit would need to be restructured. First, alternatives to u...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/j.contraception.2015.06.020

    authors： Raymond EG,Grossman D,Wiebe E,Winikoff B

    更新日期：2015-09-01 00:00:00

  • Effects of the levonorgestrel-releasing intrauterine system on cervical mucus quality and sperm penetrability.

    abstract：BACKGROUND:In levonorgestrel intrauterine system (LNG-IUS) users, the prevention of sperm penetration through cervical mucus has not been demonstrated. STUDY DESIGN:Subjects were enrolled in an investigator-blinded study to compare quality and sperm penetrability of mid-cycle cervical mucus between LNG-IUS users and h...

    journal_title：Contraception

    pub_type： 临床试验,杂志文章

    doi：10.1016/j.contraception.2010.06.006

    authors： Lewis RA,Taylor D,Natavio MF,Melamed A,Felix J,Mishell D Jr

    更新日期：2010-12-01 00:00:00

  • Effects of oral contraceptives containing 50 microgram estrogen on blood coagulation in non-Caucasian women.

    abstract：:In one of the first longitudinal studies of 163 non-Caucasian women, comprehensive coagulation, fibrinolysis and platelet function tests were performed before and during 24 months of oral contraceptive pill usage containing 50 microgram estrogen. Results of this ongoing study indicate a state of abnormal coagulability...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/0010-7824(80)90015-3

    authors： Tsakok FH,Koh S,Ratnam SS

    更新日期：1980-05-01 00:00:00

  • Perfect-use and typical-use Pearl Index of a contraceptive mobile app.

    abstract：OBJECTIVES:The Natural Cycles application is a fertility awareness-based contraceptive method that uses dates of menstruation and basal body temperature to inform couples whether protected intercourse is needed to prevent pregnancies. Our purpose with this study is to investigate the contraceptive efficacy of the mobil...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/j.contraception.2017.08.014

    authors： Berglund Scherwitzl E,Lundberg O,Kopp Kallner H,Gemzell Danielsson K,Trussell J,Scherwitzl R

    更新日期：2017-12-01 00:00:00

  • Phase I clinical trials with three formulations of anti-human chorionic gonadotropin vaccine.

    abstract：:Comparative phase I clinical trials were carried out in 5 centres with three formulations of beta-hCG-based vaccines inducing antibodies against human chorionic gonadotropin. The objectives of these trials were to determine their relative immunogenicity, duration, reversibility and safety. A total of 116 tubal ligated...

    journal_title：Contraception

    pub_type： 临床试验,杂志文章,多中心研究

    doi：10.1016/0010-7824(90)90071-3

    authors： Talwar GP,Hingorani V,Kumar S,Roy S,Banerjee A,Shahani SM,Krishna U,Dhall K,Sawhney H,Sharma NC

    更新日期：1990-03-01 00:00:00

  • Long-term follow-up of children breast-fed by mothers receiving depot-medroxyprogesterone acetate.

    abstract：:A long-term follow-up study compared development and health of 128 breast-fed children whose mothers had received depot-medroxyprogesterone acetate (depot-MPA) while lactating and 142 control children whose mothers had used mechanical contraceptives or no contraceptives or had undergone sterilization. The children, wh...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/0010-7824(84)90002-7

    authors： Jimenez J,Ochoa M,Soler MP,Portales P

    更新日期：1984-12-01 00:00:00

  • Effect of mefenamic acid on controlling irregular uterine bleeding in DMPA users.

    abstract：:The objective of this double-blind, placebo-controlled study was to evaluate the effect of mefenamic acid and placebo on controlling irregular uterine bleeding in depot-medroxyprogesterone acetate (DMPA) users. A total of 48 DMPA users attending the Family Planning Clinic, Chulalongkorn Hospital were studied, all had ...

    journal_title：Contraception

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1016/j.contraception.2004.04.003

    authors： Tantiwattanakul P,Taneepanichskul S

    更新日期：2004-10-01 00:00:00

  • Release of 19-nor-testosterone type of contraceptive steroids through different drug delivery systems into serum and breast milk of lactating women.

    abstract：:The release of contraceptive steroids through different drug delivery systems into serum and breast milk was investigated in a group of lactating women. Four women in each group were taking either a low dosage progestogen compound like norethisterone (NET) 350 micrograms or d-norgestrel (d-Ng) 50 micrograms alone or l...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/0010-7824(80)90002-5

    authors： Toddywalla VS,Mehta S,Virkar KD,Saxena BN

    更新日期：1980-03-01 00:00:00

  • Comparative effects of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic) on lipid profiles. Investigator

    abstract：:As part of a 60-week, open-label, nonrandomized, parallel, controlled study comparing a monthly contraceptive injection containing medroxyprogesterone acetate (MPA) 25 mg and estradiol cypionate (E(2)C) 5 mg (Lunelle Monthly Contraceptive Injection) and a norethindrone 0.5, 0.75, 1.0 mg/0.035 mg ethinyl estradiol (NET...

    journal_title：Contraception

    pub_type： 临床试验,杂志文章

    doi：10.1016/s0010-7824(99)00114-6

    authors： Cromie MA,Maile MH,Wajszczuk CP

    更新日期：2000-01-01 00:00:00

  • Pregnancy outcomes associated with extended use of the 52-mg 20 μg/day levonorgestrel-releasing intrauterine system beyond 60 months: A chart review of 776 women in Brazil.

    abstract：OBJECTIVE:To assess the contraceptive performance of the 52-mg 20 μg/day levonorgestrel-releasing intrauterine system (LNG-IUS, Mirena; Bayer Oy, Turku, Finland) among women who maintain the same device without changes after 60 months. STUDY DESIGN:This is a chart review study in which we assessed the charts of 766 wo...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/j.contraception.2017.10.007

    authors： Bahamondes L,Fernandes A,Bahamondes MV,Juliato CT,Ali M,Monteiro I

    更新日期：2018-03-01 00:00:00

  • Acceptability of levonorgestrel subdermal implants versus tubal ligation for long-term contraception in a rural population of Zimbabwe.

    abstract：:This prospective cohort study of 257 rural Zimbabwean women was designed to compare patient satisfaction with levonorgestrel subdermal implants (Norplant and reg;) versus tubal ligation (TL) as a method of long-term contraception. Women were equally satisfied with both methods. At 1 year, 96% of Norplant users and 97%...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/j.contraception.2004.05.004

    authors： Mitchel MJ,Thistle P

    更新日期：2004-12-01 00:00:00

  • Copper levels in maternal and fetal tissues of rabbits bearing intrauterine copper wires.

    abstract：:A study was undertaken to determine if copper wire, placed within the uterine lumen after implantation and kept in situ throughout pregnancy, results in an excessive accumulation of the metal in maternal and/or fetal tissues; and if so, what effect if any, such an accumulation may have on both mother and offspring. ...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/0010-7824(74)90060-2

    authors： Moo-Young AJ,Tatum HJ

    更新日期：1974-05-01 00:00:00

  • Postcoital use of anordrin and RU 486 for prevention of implantation in the rat.

    abstract：:Because RU 486 synergizes with anordrin and its dihydroxylated metabolite to terminate established pregnancy in the rat and rabbit, the interactions of these agents were studied at two days postcoitally in the rat. RU 486 at a dose of 4 mg/kg did not prevent pregnancy when the animals were killed 12 days post insemina...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/0010-7824(93)90038-9

    authors： Chang CC,Wang WC,Bardin CW

    更新日期：1993-04-01 00:00:00

  • Incidence of uterine rupture in second-trimester abortion with gemeprost alone compared to mifepristone and gemeprost.

    abstract：OBJECTIVES:To compare uterine rupture rates in women having a medical abortion receiving gemeprost alone to those receiving mifepristone plus gemeprost. STUDY DESIGN:We reviewed the records of women undergoing medical abortion at 13 0/7-23 6/7 weeks from January 2007 to December 2014 at a single center in Italy. Prior...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/j.contraception.2018.11.004

    authors： Morra I,Ferrara C,Sglavo G,Sansone A,Saccone G,Perriera L,Di Carlo C

    更新日期：2019-03-01 00:00:00

  • Levonorgestrel plasma concentrations and hormone profiles after insertion and after one year of treatment with a levonorgestrel-IUD.

    abstract：:Plasma concentrations of levonorgestrel, progesterone, estradiol, FSH and LH were measured in seven volunteers who had a levonorgestrel-releasing IUD inserted postmenstrually. Blood samples were collected twice weekly during a mean of 93 days immediately postmenstrually and during a mean of 41 days over the twelfth to...

    journal_title：Contraception

    pub_type： 杂志文章

    doi：10.1016/0010-7824(80)90003-7

    authors： Nilsson CG,Lähteenmäki P,Luukkainen T

    更新日期：1980-03-01 00:00:00